ASPH在肝脏恶性肿瘤发生发展中作用和机制研究进展(7)
[47] SHIMODA M, TOMIMARU Y, CHARPENTIER K P, et al. Tumor progression-related transmembrane protein aspartate-beta-hydroxylase is a target for immunotherapy of hepatocellular carcinoma[J]. Journal of Hepatology, 2012,56(5):1129-1135.[48] LONGATO L, DE LA MONTE S, KUZUSHITA N ......
您现在查看是摘要页,全文长 2578 字符。